BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8310678)

  • 1. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved yields of factor VIII from heparinized plasma.
    Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
    Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
    Vermeer C; Soute BA; Ates G; Brummelhuis HG
    Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
    Morgenthaler JJ; Zuber T; Friedli H
    Vox Sang; 1985; 48(1):8-17. PubMed ID: 3918394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can storage of thawed cryoprecipitate be extended to more than six hours?
    Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
    Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of temperature on plasma freezing under industrial conditions.
    Bravo MI; Grancha S; Jorquera JI
    Pharmeur Sci Notes; 2006 Aug; 2006(1):31-5. PubMed ID: 17694644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma factor VIII, variables affecting stability under standard blood bank conditions and correlation with recovery in concentrates.
    Pepper MD; Learoyd PA; Rajah SM
    Transfusion; 1978; 18(6):756-60. PubMed ID: 726024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
    Prowse C; Waterston YG; Dawes J; Farrugia A
    Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.
    DePalma L; Criss VR; Luban NL
    Transfusion; 1993 Sep; 33(9):717-20. PubMed ID: 8212116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Na3-citrate on the solubility of cryoprecipitate (citrate effect on cryoprecipitate).
    Faludi E; Harsányi V
    Haematologia (Budap); 1981; 14(2):207-14. PubMed ID: 6792005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
    Wensley RT; Snape TJ
    Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stability of factor VIII in heparinized plasma.
    Krachmalnicoff A; Thomas DP
    Thromb Haemost; 1983 Jun; 49(3):224-7. PubMed ID: 6410534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
    de Wit HJ; Scheer G; Muradin J; van der Does JA
    Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freezing of plasma and recovery of factor VIII.
    Carlebjörk G; Blombäck M; Pihlstedt P
    Transfusion; 1986; 26(2):159-62. PubMed ID: 3082044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.